nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cisplatinepirubicinpaclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group
|
Giuseppe Frasci |
|
1999 |
56 |
3 |
p. 237-250 14 p. |
artikel |
2 |
Cisplatin–epirubicin–paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group
|
Frasci, Giuseppe |
|
1999 |
56 |
3 |
p. 237-250 |
artikel |
3 |
Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequencebased amplification for the detection of circulating breast cancer cells
|
A.C. Lambrechts |
|
1999 |
56 |
3 |
p. 217-229 13 p. |
artikel |
4 |
Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence–based amplification for the detection of circulating breast cancer cells
|
Lambrechts, A.C. |
|
1999 |
56 |
3 |
p. 217-229 |
artikel |
5 |
Effective treatment of advanced estrogenindependent MXT mouse mammary cancers with targeted cytotoxic LHRH analogs
|
Karoly Szepeshazi |
|
1999 |
56 |
3 |
p. 265-274 10 p. |
artikel |
6 |
Effective treatment of advanced estrogen–independent MXT mouse mammary cancers with targeted cytotoxic LH–RH analogs
|
Szepeshazi, Karoly |
|
1999 |
56 |
3 |
p. 265-274 |
artikel |
7 |
pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers
|
Bradley E. Gillesby |
|
1999 |
56 |
3 |
p. 251-263 13 p. |
artikel |
8 |
pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers
|
Gillesby, Bradley E. |
|
1999 |
56 |
3 |
p. 251-263 |
artikel |
9 |
Retinoic acid receptor antagonist BMS453 inhibits the growth of normal and malignant breast cells without activating RARdependent gene expression
|
L. Yang |
|
1999 |
56 |
3 |
p. 275-289 15 p. |
artikel |
10 |
Retinoic acid receptor antagonist BMS453 inhibits the growth of normal and malignant breast cells without activating RAR–dependent gene expression
|
Yang, L. |
|
1999 |
56 |
3 |
p. 275-289 |
artikel |
11 |
Transferrin receptor overexpression enhances transferrin responsiveness and the metastatic growth of a rat mammary adenocarcinoma cell line
|
Philip G. Cavanaugh |
|
1999 |
56 |
3 |
p. 201-215 15 p. |
artikel |
12 |
Transferrin receptor overexpression enhances transferrin responsiveness and the metastatic growth of a rat mammary adenocarcinoma cell line
|
Cavanaugh, Philip G. |
|
1999 |
56 |
3 |
p. 201-215 |
artikel |
13 |
Weekly epirubicin plus lonidamine in advanced breast carcinoma
|
Cecilia Nisticò |
|
1999 |
56 |
3 |
p. 231-235 5 p. |
artikel |
14 |
Weekly epirubicin plus lonidamine in advanced breast carcinoma
|
Nisticò, Cecilia |
|
1999 |
56 |
3 |
p. 231-235 |
artikel |